Cargando…

Mycotoxin Detection in Human Samples from Patients Exposed to Environmental Molds

The goal of this study was to determine if selected mycotoxins (trichothecenes, aflatoxins, and ochratoxins) could be extracted and identified in human tissue and body fluids from patients exposed to toxin producing molds in their environment. Human urine and methanol extracted tissues and sputum we...

Descripción completa

Detalles Bibliográficos
Autores principales: Hooper, Dennis G., Bolton, Vincent E., Guilford, Frederick T., Straus, David C.
Formato: Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680627/
https://www.ncbi.nlm.nih.gov/pubmed/19468319
http://dx.doi.org/10.3390/ijms10041465
_version_ 1782166960552804352
author Hooper, Dennis G.
Bolton, Vincent E.
Guilford, Frederick T.
Straus, David C.
author_facet Hooper, Dennis G.
Bolton, Vincent E.
Guilford, Frederick T.
Straus, David C.
author_sort Hooper, Dennis G.
collection PubMed
description The goal of this study was to determine if selected mycotoxins (trichothecenes, aflatoxins, and ochratoxins) could be extracted and identified in human tissue and body fluids from patients exposed to toxin producing molds in their environment. Human urine and methanol extracted tissues and sputum were examined. Trichothecenes were tested using competitive ELISA techniques. Aflatoxins B1, B2, G1, and G2, and ochratoxin A were tested by using immunoaffinity columns and fluorometry. Test sensitivity and specificity were determined. Levels of detection for the various mycotoxins varied from 0.2 ppb for trichothecenes, 1.0 ppb for aflatoxins, and 2.0 ppb for ochratoxins. Trichothecene levels varied in urine, sputum, and tissue biopsies (lung, liver, brain) from undetectable (<0.2 ppb) to levels up to 18 ppb. Aflatoxin levels from the same types of tissues varied from 1.0 to 5.0 ppb. Ochratoxins isolated in the same type of tissues varied from 2.0 ppb to > 10.0 ppb. Negative control patients had no detectable mycotoxins in their tissues or fluids. These data show that mycotoxins can be detected in body fluids and human tissue from patients exposed to mycotoxin producing molds in the environment, and demonstrate which human tissues or fluids are the most likely to yield positive results.
format Text
id pubmed-2680627
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-26806272009-05-22 Mycotoxin Detection in Human Samples from Patients Exposed to Environmental Molds Hooper, Dennis G. Bolton, Vincent E. Guilford, Frederick T. Straus, David C. Int J Mol Sci Article The goal of this study was to determine if selected mycotoxins (trichothecenes, aflatoxins, and ochratoxins) could be extracted and identified in human tissue and body fluids from patients exposed to toxin producing molds in their environment. Human urine and methanol extracted tissues and sputum were examined. Trichothecenes were tested using competitive ELISA techniques. Aflatoxins B1, B2, G1, and G2, and ochratoxin A were tested by using immunoaffinity columns and fluorometry. Test sensitivity and specificity were determined. Levels of detection for the various mycotoxins varied from 0.2 ppb for trichothecenes, 1.0 ppb for aflatoxins, and 2.0 ppb for ochratoxins. Trichothecene levels varied in urine, sputum, and tissue biopsies (lung, liver, brain) from undetectable (<0.2 ppb) to levels up to 18 ppb. Aflatoxin levels from the same types of tissues varied from 1.0 to 5.0 ppb. Ochratoxins isolated in the same type of tissues varied from 2.0 ppb to > 10.0 ppb. Negative control patients had no detectable mycotoxins in their tissues or fluids. These data show that mycotoxins can be detected in body fluids and human tissue from patients exposed to mycotoxin producing molds in the environment, and demonstrate which human tissues or fluids are the most likely to yield positive results. Molecular Diversity Preservation International (MDPI) 2009-04-01 /pmc/articles/PMC2680627/ /pubmed/19468319 http://dx.doi.org/10.3390/ijms10041465 Text en © 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Hooper, Dennis G.
Bolton, Vincent E.
Guilford, Frederick T.
Straus, David C.
Mycotoxin Detection in Human Samples from Patients Exposed to Environmental Molds
title Mycotoxin Detection in Human Samples from Patients Exposed to Environmental Molds
title_full Mycotoxin Detection in Human Samples from Patients Exposed to Environmental Molds
title_fullStr Mycotoxin Detection in Human Samples from Patients Exposed to Environmental Molds
title_full_unstemmed Mycotoxin Detection in Human Samples from Patients Exposed to Environmental Molds
title_short Mycotoxin Detection in Human Samples from Patients Exposed to Environmental Molds
title_sort mycotoxin detection in human samples from patients exposed to environmental molds
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680627/
https://www.ncbi.nlm.nih.gov/pubmed/19468319
http://dx.doi.org/10.3390/ijms10041465
work_keys_str_mv AT hooperdennisg mycotoxindetectioninhumansamplesfrompatientsexposedtoenvironmentalmolds
AT boltonvincente mycotoxindetectioninhumansamplesfrompatientsexposedtoenvironmentalmolds
AT guilfordfrederickt mycotoxindetectioninhumansamplesfrompatientsexposedtoenvironmentalmolds
AT strausdavidc mycotoxindetectioninhumansamplesfrompatientsexposedtoenvironmentalmolds